Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities
Net loss	$ (1,844)	$ (43,773)
Adjustments to reconcile net income to net cash provided by (used in) operating activities
Non-cash write downs of inventory	8,495	699
Accretion expense	1,936	(544)
Depreciation of property and equipment and amortization of intangible assets	12,131	7,050
Amortization of operating right-of-use assets	1,074	2,269
Share-based compensation	7,819	8,215
Deferred income tax (recovery) expense	(787)	285
(Gain) loss on fair value of warrants and purchase option derivative	(53,058)	25,301
Revaluation of contingent consideration	153	2,990
Impairment of intangible assets		3,633
Impairment of goodwill		5,007
Loss on disposal of fixed assets	929	37
Release of indemnification asset	3,973	3,796
Forgiveness of principal and interest on loans		(766)
Unrealized and realized foreign exchange loss	50	5,838
Unrealized and realized loss (gain) on investments	234	(6,192)
Changes in operating assets and liabilities
Receivables	475	(950)
Inventory	208	(9,879)
Prepaid expense and deposits	1,474	(507)
Deposits	206
Other assets	461	389
Accounts payable and accrued liabilities and other payables	(8,299)	639
Operating lease liability	(614)	(1,889)
Other liability	(10,353)
Contingent consideration payable	(410)	(11,394)
Corporate income tax payable	5	(293)
Deferred revenue	766
Net cash used in operating activities	(34,976)	(10,076)
Investing activities
Investment in property and equipment	(12,500)	(10,856)
Investment in intangible assets	(1,330)	(40)
Principal payments received on lease receivable	392	359
Distributions of earnings from associates		469
Deposits for property and equipment	(10,036)	(10,583)
Deposits for business acquisition	(852)
Payments made for land contracts	(429)
Cash received on acquisition	24,716
Cash portion of consideration paid in acquisitions, net of cash acquired		(42,736)
Net cash used in investing activities	(39)	(63,387)
Financing activities
Proceeds from options and warrants exercised	24,158	12,921
Loan principal paid	(5,203)
Loan amendment fee paid	(1,200)
Proceeds from loans payable		766
Cash distributions to NJ partners	(1,436)
Capital contributions paid to non-controlling interests	(448)	(383)
Payments of contingent consideration	(6,630)	(18,274)
Payments made for financing obligations	(460)
Proceeds from private placement, net of share issuance costs		173,477
Net cash provided by financing activities	8,781	168,507
Net (decrease) increase in cash and cash equivalents during the period	(26,234)	95,044
Net effects of foreign exchange	(4,377)	(89)
Cash and cash equivalents, beginning of period	79,642	59,226
Cash and cash equivalents, end of period	49,031	154,181
Supplemental disclosure with respect to cash flows
Income taxes paid	9,213	16,381
Interest paid	14,641	13,290
Lease termination fee paid	3,300
Non-cash transactions
Shares issued as consideration for acquisitions	294,800	34,427
Promissory note issued as consideration for acquisitions		6,750
Shares issued for liability settlement	22	57
Accrued capital purchases	$ 9,776	$ 336